Medication info

Wipens Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Approval status
Expired

MFDS item code 201906275 · Approved 2019.09.03

This product's status changed to Expired on 2024.09.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treats gastrointestinal disorders (such as ulcers, gastritis, and gastroesophageal reflux disease) and prevents Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant therapy to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase as needed. In severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the evening before surgery.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treats gastrointestinal disorders (such as ulcers, gastritis, and gastroesophageal reflux disease) and prevents Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAIDs
View approved original text

This medication is effective for gastrointestinal disorders such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson’s syndrome when administered before anesthesia and to treat postoperative ulcers that may occur. It helps with gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it is widely used for the treatment and prevention of various gastrointestinal diseases.

How to take

Adult dose

○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant therapy to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase as needed. In severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the evening before surgery.

Precautions

This medication should not be used in patients undergoing dialysis treatment. Patients with a history of allergies to this medication or its components should also avoid taking it. Patients with a history of acute porphyria, a rare blood disorder, should not be administered this medication as it may trigger seizures. This medication should not be used in patients with impaired renal function or kidney diseases. It is also not recommended for patients who have undergone upper gastrointestinal surgery. Women who are pregnant or may become pregnant should not take this medication. It is advisable to avoid administering this drug to premature infants or newborns. Patients on a diet that restricts potassium intake should also avoid this medication. Patients with liver dysfunction should use this medication with caution, and those with a history of drug allergies should use it carefully. Elderly patients and those with a history of decreased renal function require caution. In cases where NSAIDs are used simultaneously, regular monitoring is needed, especially for elderly patients or those with a history of peptic ulcers. This medication may obscure the symptoms of gastric cancer, so it should be used with caution in patients with gastric ulcers or middle-aged patients with recent or changed dyspeptic symptoms, after confirming malignancy. Patients with helicobacter pylori-induced gastric or duodenal ulcers require eradication therapy. Patients in severe intensive care may be at risk of gastric stone formation, so caution is needed. Patients with hypophosphatemia should be careful, as the aluminum content of this medication may interfere with phosphate absorption. Patients who have difficulty swallowing should be cautious due to the risk of respiratory complications. While taking this medication, serious allergic reactions such as anaphylactic shock may occasionally occur; if abnormal symptoms arise, administration should be discontinued immediately and treated. If allergy symptoms such as skin rash, urticaria, angioedema, fever, or bronchospasm occur, discontinue use and consult a doctor. Blood tests may show decreased white blood cell or platelet counts; if such symptoms appear, discontinue taking the medication immediately. Symptoms of liver dysfunction may rarely occur, so if jaundice or hepatitis symptoms are noted, administration should be stopped immediately. Abnormalities in circulation such as cardiac arrhythmias or vasculitis have also been reported rarely, requiring caution. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and stool color may change, although this does not require special treatment. Neurological symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, headache, and feeling of heaviness may also occur rarely, so inform a doctor if any abnormal symptoms are present. Endocrine symptoms such as gynecomastia, increased milk secretion, erectile dysfunction, and decreased libido have been reported very rarely. Myalgia and arthralgia may occur, and in serious cases, it may progress to rhabdomyolysis; therefore, discontinue use immediately if symptoms appear. Skin rashes, hair loss, and itching have been reported rarely, and the tongue may turn black but will recover naturally. To avoid long-term use, it is better to switch to another drug if there is no treatment effect. Elderly patients, those with chronic pulmonary disease, diabetics, and immunocompromised patients may be at increased risk of pneumonic infections while taking this medication, so caution is advised. If dizziness or drowsiness occurs after taking this medication, it is advisable to avoid driving or operating dangerous machinery. This medication may interact with other drugs; therefore, especially when taken with anticoagulants or some antibiotics and analgesics, consult a doctor or pharmacist. It is safer for pregnant or breastfeeding women not to take this medication. Safety in children has not been established, so it is advisable to avoid use whenever possible. This medication may affect certain clinical test results, so it is good to inform the healthcare providers at the time of testing. In case of overdose, treatment such as vomiting or gastric lavage may be necessary, and may be removable through hemodialysis.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 47 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • excitement
  • insomnia
  • headache
  • feeling of heaviness in the head
  • sense of illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hepatic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight, sealed container and kept at a temperature between 1°C to 30°C at room temperature. Storing it this way helps maintain the medication's efficacy and prevents deterioration.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.